Part B Drugs – Page 3 – MedPAC

An official website of the United States Government —

Here’s how you know

MedPAC > Our Work > Part B Drugs

Part B Drugs

Showing 21 - 30 out of 202

Sep 01, 2022 / Presentations

Addressing high prices of drugs covered under Medicare Part B

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Jun 15, 2022 / Reports

June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Executive summary (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Chapters

Chapter 4: Addressing high prices of drugs covered under Medicare Part B (June 2022 report)

Research Areas:

Drugs, Devices, and Tests

Jun 15, 2022 / Chapters

Appendix A: Commissioners’ voting on recommendations (June 2022 report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues

Jun 15, 2022 / Press Releases

MedPAC releases June 2022 Report to the Congress: Medicare and the Health Care Delivery System

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues

Apr 07, 2022 / Presentations

Addressing high prices of drugs covered under Medicare Part B

Research Areas:

Drugs, Devices, and Tests

Apr 07, 2022 / Transcripts

April 2022 meeting transcript

Research Areas:

Ambulatory Care Settings, Drugs, Devices, and Tests, Medicare Spending and Financing, Quality

Oct 07, 2021 / Presentations

Addressing high prices of pharmaceutical products (and other technologies) covered under Medicare

Research Areas:

Drugs, Devices, and Tests